Search PDMR transactions

Notifier
Name of person with notification obligation
Michael James Owens
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Michael James Owens
Position
Chief Financial Officer (CFO)
Initial notification
No
Amendment
Yes
Details of amendment
Felstavning korrigerad avseende emittentens firma
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Lipigon Pharmaceuticals AB SE0015382072 Acquisition 10,000 Quantity 6.75 SEK 21/06/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB SE0015382072 Acquisition 21/06/2021 NASDAQ STOCKHOLM AB 10,000 (Quantity) 6.75 SEK
Total: 10,000
<< Back